GC PHARMA
⚠️ High Risk
FEI: 3024515744 • Jeollanam-Do • SOUTH KOREA
FEI Number
3024515744
Location
Jeollanam-Do
Country
SOUTH KOREAAddress
40 Sandan-Gil, Hwasun-Eup, , Hwasun, Jeollanam-Do, , South Korea
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO LICENSE
The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/27/2023 | 57CL02INFLUENZA VIRUS VACCINE | 71NO LICENSE | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is GC PHARMA's FDA import refusal history?
GC PHARMA (FEI: 3024515744) has 1 FDA import refusal record(s) in our database, spanning from 12/27/2023 to 12/27/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GC PHARMA's FEI number is 3024515744.
What types of violations has GC PHARMA received?
GC PHARMA has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about GC PHARMA come from?
All FDA import refusal data for GC PHARMA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.